Alpheus Medical is developing a non-thermal, tumor-selective cancer therapy using low-intensity diffuse ultrasound and oral 5-aminolevulinic acid, specifically targeting glioblastoma.

Myosin Therapeutics is a biotechnology company developing therapies for cancer and neurological disorders, including treatments for glioblastoma and methamphetamine use disorder.

Modifi Bio is a biotech company that specializes in DNA modification for targeting cancer, with the goal of improving cancer therapy and patient care.